Creative Medical Technology Holdings, Inc. reported earnings results for the first quarter ended March 31, 2024. For the first quarter, the company reported net loss was USD 1.04 million compared to USD 1.05 million a year ago. Basic loss per share from continuing operations was USD 0.73 compared to USD 0.75 a year ago.
Creative Medical Technology Holdings, Inc.
Equities
CELZ
US22529Y4089
Biotechnology & Medical Research
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
4.395 USD | +1.75% | -1.62% | -4.66% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-4.66% | 5.93M | |
+19.33% | 125B | |
+13.95% | 108B | |
-3.53% | 24.57B | |
+3.35% | 22.82B | |
-10.44% | 18.19B | |
-41.48% | 16.54B | |
-12.62% | 16.5B | |
+0.99% | 13.39B | |
+21.79% | 11.1B |
- Stock Market
- Equities
- CELZ Stock
- News Creative Medical Technology Holdings, Inc.
- Creative Medical Technology Holdings, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024